GlassScriptPhysician profile
Brandon Lee
NPI 1962909366
$2,031.36
in general payments reported to CMS, 2019-2025
15 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.07 · 2021: $458 · 2022: $391 · 2023: $367 · 2024: $498 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $295.81 | 2021-2023 | Grafix, Stravix |
| Stryker Corporation | $286.09 | 2021-2022 | |
| Treace Medical Concepts, INC. | $193.82 | 2022 | |
| Lifenet Health | $183.19 | 2024 | Theragenesis Wound Matrix |
| Medtronic, INC. | $169.77 | 2025 | Inceptiv |
| Orthofix Medical, INC. | $154.75 | 2022-2023 | Trinity Elite, Truelok, Truelok System |
| Forma Medical | $142.50 | 2024 | Optimalakin |
| Averitas Pharma INC. | $136.70 | 2024 | Qutenza |
| Kerecis Limited | $126.16 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Cardiovascular Systems INC. | $122.56 | 2021 | |
| Angiodynamics, INC. | $106.25 | 2023 | Auryon Laser System 100-120 Vac |
| Paragon 28, INC. | $35.42 | 2024 | Monster |
| Depuy Synthes Sales INC. | $34.37 | 2021 | |
| Abbott Laboratories | $22.07 | 2019 | |
| Paratek Pharmaceuticals, INC. | $21.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.